EuroHedge was proud to have Duchenne UK as our official charity partner.
"COVID-19 has slowed DMD research but it will not stop us"
Two families a week in the UK hear the devastating news that their child has Duchenne muscular dystrophy (DMD), a progressive life-limiting muscle-wasting disease.
Duchenne UK is going further to find effective treatments for DMD, by funding ground-breaking medical research. We’re doing it faster, by accelerating the development of new treatments. And we’re here to support every family affected and ensure they receive the best possible care. For more information visit www.duchenneuk.org/donate .